ECL
84
2
APA
30
5
HST
39
-5
PVH
67
-2
FFIV
64
2
FSLR
76
3
PSA
48
2
PYPL
31
2
NOV
48
3
GME
75
-14
CFG
56
4
EBAY
43
-2
TGNA
66
2
K
42
-3
SJM
36
-2
XEL
60
-2
TXT
75
6
GOOG
75
2
CF
44
-3
SYF
83
2
ECL
84
2
APA
30
5
HST
39
-5
PVH
67
-2
FFIV
64
2
FSLR
76
3
PSA
48
2
PYPL
31
2
NOV
48
3
GME
75
-14
CFG
56
4
EBAY
43
-2
TGNA
66
2
K
42
-3
SJM
36
-2
XEL
60
-2
TXT
75
6
GOOG
75
2
CF
44
-3
SYF
83
2
Financhill
Back

CytoSorbents 10K Form

Sell
25

CTSO
CytoSorbents

Last Price:
0.96
Seasonality Move:
-5.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09 10Q CTSO/CytoSorbents Quarterly
2023-08-01 10Q CTSO/CytoSorbents Quarterly
2023-05-02 10Q CTSO/CytoSorbents Quarterly
2022-11-03 10Q CTSO/CytoSorbents Quarterly
2022-08-02 10Q CTSO/CytoSorbents Quarterly
2022-05-03 10Q CTSO/CytoSorbents Quarterly

Receive CTSO News And Ratings

See the #1 stock for the next 7 days that we like better than CTSO

CTSO Financial Statistics

Sales & Book Value

Annual Sales: $31.08M
Cash Flow: $-4.96M
Price / Cash Flow: 0
Annual Sales: $0.35
Price / Book: 2.78

Profitability

EPS (TTM): -0.59000
Net Income (TTM): $-27.54M
Gross Margin: $17.13M
Return on Equity: -121.04%
Return on Assets: -53.41%

CytoSorbents Earnings Forecast

Key CytoSorbents Financial Ratios

  • The Gross Profit Margin over the past 16 years for CTSO is 55.10%.
  • The Selling, General & Administrative Expenses for CTSO have been equal to 121.84% of Gross Profit Margin.
  • The Research & Development expenses have been 50.60% of Revenue.
  • The Interest Expense is -15.31% of Operating Income.
  • The Net Earning history of CTSO is -91.71% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

CytoSorbents Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: CTSO
CUSIP: 23283X
Website: cytosorbents.com

Debt

Debt-to-Equity Ratio: 0.23
Current Ratio: 1.49
Quick Ratio: 1.15

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CTSO Technical Analysis vs Fundamental Analysis

Sell
25
CytoSorbents (CTSO) is a Sell

Is CytoSorbents a Buy or a Sell?

  • CytoSorbents stock is rated a Sell
    The current CytoSorbents [CTSO] share price is $0.97. The Score for CTSO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.